H.R. 2430 · 115th Congress
FDA Reauthorization Act of 2017
- Stage
- Signed by the president
- Sponsor
- Greg Walden
- Introduced
- 2017-05-16
- Latest action
- 2017-08-18 · Signed by President.
Subjects
Executive agency funding and structure
Administrative law and regulatory procedures
Congressional oversight
Government buildings, facilities, and property
Performance measurement
Government studies and investigations
Health
Health information and medical records
User charges and fees
Fraud offenses and financial crimes
Child health
Infectious and parasitic diseases
Medical research
Licensing and registrations
Cancer
Drug therapy
Medical tests and diagnostic methods
Department of Health and Human Services
Health technology, devices, supplies
Health personnel
Small business
Hearing, speech, and vision care
Government information and archives
Public-private cooperation
Prescription drugs
Marketing and advertising
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Manufacturing